Calcimedica, Common Stock Stock Analysis
| CALC Stock | 2.78 0.03 1.07% |
CalciMedica, Common Stock is undervalued with Real Value of 5.58 and Target Price of 14.0. The main objective of CalciMedica, Common stock analysis is to determine its intrinsic value, which is an estimate of what CalciMedica, Common Stock is worth, separate from its market price. There are two main types of CalciMedica, Common's stock analysis: fundamental analysis and technical analysis.
The CalciMedica, Common stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CalciMedica, Common's ongoing operational relationships across important fundamental and technical indicators.
CalciMedica, |
CalciMedica, Stock Analysis Notes
About 17.0% of the company shares are held by company insiders. The book value of CalciMedica, Common was currently reported as 1.42. The company recorded a loss per share of 1.11. CalciMedica, Common Stock had not issued any dividends in recent years. The entity had 1:14 split on the 20th of March 2023. For more info on CalciMedica, Common Stock please contact Rachel Leheny at 858-952-5500 or go to https://www.calcimedica.com.CalciMedica, Common Stock Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. CalciMedica, Common's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding CalciMedica, Common Stock or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| CalciMedica, Common generated a negative expected return over the last 90 days | |
| CalciMedica, Common has high historical volatility and very poor performance | |
| CalciMedica, Common has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.36 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CalciMedica, Common generates negative cash flow from operations | |
| CalciMedica, Common has a frail financial position based on the latest SEC disclosures | |
| About 17.0% of the company shares are held by company insiders | |
| Latest headline from investing.com: Insider Activity Roundup Fridays Key Buys and Sells in US Stocks |
CalciMedica, Common Stock Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CalciMedica, Common previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
CalciMedica, Largest EPS Surprises
Earnings surprises can significantly impact CalciMedica, Common's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-08 | 2024-06-30 | -0.53 | -0.36 | 0.17 | 32 | ||
2023-11-09 | 2023-09-30 | -1.14 | -0.82 | 0.32 | 28 | ||
2022-03-10 | 2021-12-31 | -5.12 | -5.74 | -0.62 | 12 |
CalciMedica, Common Environmental, Social, and Governance (ESG) Scores
CalciMedica, Common's ESG score is a quantitative measure that evaluates CalciMedica, Common's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of CalciMedica, Common's operations that may have significant financial implications and affect CalciMedica, Common's stock price as well as guide investors towards more socially responsible investments.
CalciMedica, Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 37.88 M.CalciMedica, Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.82) | (2.68) | |
| Return On Capital Employed | (2.68) | (2.82) | |
| Return On Assets | (2.82) | (2.68) | |
| Return On Equity | (4.21) | (4.00) |
Management Efficiency
CalciMedica, Common Stock has return on total asset (ROA) of (0.6492) % which means that it has lost $0.6492 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8376) %, meaning that it created substantial loss on money invested by shareholders. CalciMedica, Common's management efficiency ratios could be used to measure how well CalciMedica, Common manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -2.68. In addition to that, Return On Capital Employed is expected to decline to -2.82. As of December 18, 2024, Total Assets is expected to decline to about 11.6 M. In addition to that, Non Current Assets Total is expected to decline to about 551 K| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.82 | 1.73 | |
| Tangible Book Value Per Share | 1.82 | 1.73 | |
| Enterprise Value Over EBITDA | (0.21) | (0.22) | |
| Price Book Value Ratio | 1.57 | 1.65 | |
| Enterprise Value Multiple | (0.21) | (0.22) | |
| Price Fair Value | 1.57 | 1.65 | |
| Enterprise Value | -9.4 M | -8.9 M |
The decision-making processes within CalciMedica, Common are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Return On Assets (0.65) | Return On Equity (0.84) |
Technical Drivers
As of the 18th of December 2024, CalciMedica, Common shows the Standard Deviation of 5.71, mean deviation of 3.35, and Risk Adjusted Performance of (0.04). CalciMedica, Common Stock technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.CalciMedica, Common Stock Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CalciMedica, Common middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CalciMedica, Common Stock. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
CalciMedica, Common Stock Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CalciMedica, Common insiders, such as employees or executives, is commonly permitted as long as it does not rely on CalciMedica, Common's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CalciMedica, Common insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CalciMedica, Common Predictive Daily Indicators
CalciMedica, Common intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CalciMedica, Common stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
CalciMedica, Common Corporate Filings
| 13th of December 2024 Other Reports | ViewVerify | |
F4 | 6th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 26th of November 2024 The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act | ViewVerify |
F3 | 15th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 13th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 8th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 6th of November 2024 An amendment to the original Schedule 13D filing | ViewVerify |
CalciMedica, Common Forecast Models
CalciMedica, Common's time-series forecasting models are one of many CalciMedica, Common's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CalciMedica, Common's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About CalciMedica, Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how CalciMedica, Common prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CalciMedica, shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CalciMedica, Common. By using and applying CalciMedica, Stock analysis, traders can create a robust methodology for identifying CalciMedica, entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Current CalciMedica, Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CalciMedica, analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CalciMedica, analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 14.0 | Strong Buy | 3 | Odds |
Most CalciMedica, analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CalciMedica, stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CalciMedica, Common Stock, talking to its executives and customers, or listening to CalciMedica, conference calls.
CalciMedica, Stock Analysis Indicators
CalciMedica, Common Stock stock analysis indicators help investors evaluate how CalciMedica, Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CalciMedica, Common shares will generate the highest return on investment. By understating and applying CalciMedica, Common stock analysis, traders can identify CalciMedica, Common position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 1.5 M | |
| Common Stock Shares Outstanding | 4.5 M | |
| Total Stockholder Equity | 8.2 M | |
| Property Plant And Equipment Net | 167 K | |
| Cash And Short Term Investments | 11.2 M | |
| Cash | 5.5 M | |
| Accounts Payable | 1.4 M | |
| Net Debt | -5.5 M | |
| 50 Day M A | 3.5855 | |
| Total Current Liabilities | 4 M | |
| Other Operating Expenses | 21.9 M | |
| Non Current Assets Total | 580 K | |
| Non Currrent Assets Other | 413 K | |
| Stock Based Compensation | 12 M |
Complementary Tools for CalciMedica, Stock analysis
When running CalciMedica, Common's price analysis, check to measure CalciMedica, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica, Common is operating at the current time. Most of CalciMedica, Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica, Common's price. Additionally, you may evaluate how the addition of CalciMedica, Common to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |